文献速递神经眼科小儿眼科与斜弱视

新诊断脑肿瘤青少年的眼科检查发现

Ophthalmological Findings in Youths With a Newly Diagnosed Brain Tumor.
PubMed 文献 · JAMA Ophthalmol · 2022-01-01

这项荷兰全国性前瞻性队列研究纳入170例新诊断脑肿瘤的0至18岁青少年,在诊断4周内进行标准化眼科检查,结果显示78.8%存在异常眼科发现,59.4%诊断时有视觉症状,无视觉症状者中65.2%仍有眼科异常。

要点

  • 新诊断脑肿瘤青少年中78.8%存在异常眼科发现,59.4%诊断时有视觉症状。
  • 无视视觉症状的69例中有45例(65.2%)眼科检查仍发现异常。
  • 最常见异常为视乳头水肿(52.4%)、凝视缺陷(33.5%)和视野缺损(28.1%)。

核心结论

  • 研究结果提示,新诊断脑肿瘤青少年中异常眼科发现患病率高,且与是否存在视觉症状无关。
  • 这些发现支持对该患者群体进行标准化眼科检查,并提高眼科医生及转诊肿瘤科、神经科和神经外科医生对眼科异常的警觉。

研究设计与样本

  • 荷兰全国性前瞻性队列研究,2019年5月15日至2021年8月11日在4家医院连续纳入170例新诊断脑肿瘤的0至18岁青少年,包括儿科肿瘤专科三级转诊中心。
  • 在脑肿瘤诊断后4周内进行标准化综合眼科检查,包括斜视与视功能评估、视力测试、视野检查和检眼镜检查。

主要发现

  • 170例中男性96例(56.5%),中位年龄8.3岁(范围0.2-17.8岁);幕下肿瘤82例(48.2%)、幕上中线肿瘤53例(31.2%)、大脑半球肿瘤35例(20.6%)。
  • 161例(94.7%)接受斜视与视功能评估(术前67例[41.6%],术后94例[58.4%]);152例(89.4%)接受视力测试(术前63例[41.4%],术后89例[58.6%]);121例(71.2%)接受视野检查(术前49例[40.4%],术后72例[59.6%]);164例(96.5%)接受检眼镜检查(术前82例[50.0%],术后82例[50.0%])。
  • 101例(59.4%)诊断时存在视觉症状;134例(78.8%)眼科检查发现异常。
  • 最常见异常为视乳头水肿86/164例(52.4%)、凝视缺陷54/161例(33.5%)、视野缺损32/114例(28.1%)、眼球震颤40/161例(24.8%)、斜视32/161例(19.9%)、视力下降13/152例(8.6%)。
  • 诊断时无视觉症状的69例中45例(65.2%)眼科检查存在异常。

临床怎么用

  • 原文结论认为这些发现支持对该患者群体进行标准化眼科检查,并提高眼科医生及转诊肿瘤科、神经科和神经外科医生对眼科异常的警觉。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Visual impairment is an irreversible adverse effect in individuals who experienced a childhood brain tumor. Ophthalmological evaluation at diagnosis enables early detection of vision loss, decision-making about treatment, and when applicable, the timely use of visual interventions. However, awareness of visual impairment in clinical practice is suboptimal, and adherence to ophthalmological evaluation needs to be improved. OBJECTIVE: To assess the prevalence and types of abnormal ophthalmological findings in youths with a newly diagnosed brain tumor. DESIGN, SETTING, AND PARTICIPANTS: In this nationwide, prospective cohort study, youths aged 0 to 18 years with a newly diagnosed brain tumor between May 15, 2019, and August 11, 2021, were consecutively enrolled in 4 hospitals in the Netherlands, including the dedicated tertiary referral center for pediatric oncology care. EXPOSURES: A standardized and comprehensive ophthalmological examination, including orthoptic evaluation, visual acuity testing, visual field examination, and ophthalmoscopy, was performed within 4 weeks from brain tumor diagnosis. MAIN OUTCOMES AND MEASURES: The main outcomes were prevalence and types of visual symptoms and abnormal ophthalmological findings at brain tumor diagnosis. RESULTS: Of 170 youths included in the study (96 [56.5%] male; median age, 8.3 years [range, 0.2-17.8 years]), 82 (48.2%) had infratentorial tumors; 53 (31.2%), supratentorial midline tumors; and 35 (20.6%), cerebral hemisphere tumors. A total of 161 patients (94.7%) underwent orthoptic evaluation (67 [41.6%] preoperatively; 94 [58.4%] postoperatively); 152 (89.4%), visual acuity testing (63 [41.4%] preoperatively; 89 [58.6%] postoperatively); 121 (71.2%), visual field examination (49 [40.4%] preoperatively; 72 [59.6%] postoperatively); and 164 (96.5%), ophthalmoscopy (82 [50.0%] preoperatively; 82 [50.0%] postoperatively). Overall, 101 youths (59.4%) presented with visual symptoms at diagnosis. Abnormal findings were found in 134 patients (78.8%) during ophthalmological examination. The most common abnormal findings were papilledema in 86 of 164 patients (52.4%) who underwent ophthalmoscopy, gaze deficits in 54 of 161 (33.5%) who underwent orthoptic evaluation, visual field defects in 32 of 114 (28.1%) with reliable visual field examination, nystagmus in 40 (24.8%) and strabismus in 32 (19.9%) of 161 who underwent orthoptic evaluation, and decreased visual acuity in 13 of 152 (8.6%) with reliable visual acuity testing. Forty-five of 69 youths (65.2%) without visual symptoms at diagnosis had ophthalmological abnormalities on examination. CONCLUSIONS AND RELEVANCE: The results of this study suggest that there is a high prevalence of abnormal ophthalmological findings in youths at brain tumor diagnosis regardless of the presence of visual symptoms. These findings support the need of standardized ophthalmological examination and the awareness of ophthalmologists and referring oncologists, neurologists, and neurosurgeons for ophthalmological abnormalities in this patient group.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Nuijts MA, Stegeman I, van Seeters T, et al. Ophthalmological Findings in Youths With a Newly Diagnosed Brain Tumor. JAMA Ophthalmol. 2022. PMID: 36107418. doi:10.1001/jamaophthalmol.2022.3628

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。